Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dyadem is a leading provider of Quality Lifecycle Management (QLM) and Risk Management software solutions, primarily serving the life sciences, medical device, and pharmaceutical industries. The company's flagship products, such as Stature and PHA-Pro, enable organizations to identify, manage, and mitigate operational and regulatory risks throughout the product lifecycle. Dyadem's solutions are specifically designed to help pharmaceutical and medtech companies comply with international standards like ISO 14971 and ICH Q9. Following its acquisition by IHS in 2011, its technology has been integrated into broader enterprise risk and engineering intelligence portfolios, eventually becoming part of Accuris.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dyadem.